Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Inb-100: Pilot Study of Donor Derived, Ex-Vivo Expanded/Activated Gamma Delta T Cell Infusion Following Haploidentical Hematopoietic Stem Cell Transplantation and Post-Transplant Cyclophosphamide

Joseph P. McGuirk, Sunil Abhyankar, Trishna Goswami, Mariska ter Haak, Kate Rochlin, Lawrence S. Lamb

Blood (2024) 144 (Supplement 1): 4823.

https://doi.org/10.1182/blood-2024-199153

Published: 2024

Journal Articles

Gamma-Delta (γδ) CAR-T Cells Lacking the CD3z Signaling Domain Enhance Targeted Killing of Tumor Cells and Preserve Healthy Tissues

Lei Ding, Yanjie Li, Jixue Li, Mariska ter Haak, Lawrence S. Lamb

Blood (2023) 142 (Supplement 1): 6835.

https://doi.org/10.1182/blood-2023-187287

Published: 2023

Journal Articles

Inb-100: A Pilot Study of Donor Derived, Ex-Vivo Expanded/Activated Gamma-Delta T Cell (EAGD) Infusion Following Haploidentical Hematopoietic Stem Cell Transplantation and Post-Transplant Cyclophosphamide (PTCy)

Joseph P McGuirk, Sunil Abhyankar, Trishna Goswami, Halie Juarez, Mariska ter Haak, Tyce Bruns, Samantha Youngblood, Lawrence S. Lamb

Blood (2023) 142 (Supplement 1): 4853.

https://doi.org/10.1182/blood-2023-181184

Published: 2023

Journal Articles

Relapse Prophylaxis Post-Haploidentical Bone Marrow Transplantation and Cyclophosphamide (Haplo/Cy) By Infusion of Donor-Derived Expanded/Activated Gd T Cells: A Phase I Trial

Joseph P. McGuirk, Sunil H Abhyankar, Trishna Goswami, Rupal Soder, Mariska ter Haak, Tyce Bruns, Samantha Langford Youngblood, Lawrence S. Lamb, Jr.

Blood (2022) 140 (Supplement 1): 7464–7465.

https://doi.org/10.1182/blood-2022-169819

Published: 2022

Journal Articles

First-in-Human Phase I Trial of Adoptive Immunotherapy with Ex Vivo Expanded and Activated Γδ T Cells Following Haploidentical Bone Marrow Transplantation and Post-BMT Cyclophosphamide

Lawrence S. Lamb, Jr., PhD, Melissa Jo Beelen, Mjbeelen@incysus.com, Samantha Langford Youngblood, BS, Rupal Soder, PhD, Sunil Abhyankar, MD, Joseph P. McGuirk, DO

Blood (2020) 136 (Supplement 1): 9.

https://doi.org/10.1182/blood-2020-142876

Published: 2020

Journal Articles

A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrelated Donor Hematopoietic Stem Cell Transplantation

Omer Jamy, MD, Racquel Innis-Shelton, MD, Susan Bal, MDMBBS, Ravi K. Paluri, MD, Samina Karim, Joseph H. Chewning, MD, Donna Salzman, MD, Luciano J. Costa, MD PhD, Antonio Di Stasi, MD, Lawrence S. Lamb, Jr., PhD, Shin Mineishi, Ayman Saad, MD

Blood (2019) 134 (Supplement_1): 2003.

https://doi.org/10.1182/blood-2019-129536

Published: 2019

Journal Articles

Standard Processing of Apheresis Products for HSCT Provides Significant Cost Savings over Automated Processing without Impact on Time or Product Quality

Lauren Bongo, MLS, Ravi Bhatia, MD, Lawrence S. Lamb, Jr., PhD

Blood (2018) 132 (Supplement 1): 5693.

https://doi.org/10.1182/blood-2018-99-119295

Published: 2018

Journal Articles

Impact of T-Cell Dose on Gvhd Risk after Allogeneic HLA-Matched PBSC Transplantation

Ayman Saad, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Stephen R. Spellman, Mukta Arora, MD, Lawrence S. Lamb, Jr., PhD, Shahrukh K. Hashmi, MD MPH

Blood (2018) 132 (Supplement 1): 3410.

https://doi.org/10.1182/blood-2018-99-113513

Published: 2018

Journal Articles

Autologous Hematopoietic Progenitor Cells Mobilization with Combination of Pegfilgrastim and Plerixafor: Efficacy and Cost Assessment

Luciano J. Costa, MD PhD, Racquel Innis-Shelton, MD, Joscelyn Bowersock, MT, Ayman Saad, MD, Donna Salzman, MD, Antonio Di Stasi, MD, Nicole Watts, PharmD, Lawrence S. Lamb, Jr., PhD

Blood (2017) 130 (Supplement 1): 4708.

https://doi.org/10.1182/blood.V130.Suppl_1.4708.4708

Published: 2017

Journal Articles

Favorable Immune Reconstitution Profile after Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide

Omer Hassan Jamy, MD, Ayman Saad, MD, Rachael Orlandella, BS, Samantha B Langford, BS, Ravi K. Paluri, MD, Racquel Innis-Shelton, MD, Shin Mineishi, MD, Lawrence S. Lamb, Jr., PhD

Blood (2016) 128 (22): 2236.

https://doi.org/10.1182/blood.V128.22.2236.2236

Published: 2016

Journal Articles

Recovery of CMV-Specific T Cells Following Alternative Donor Allogeneic Transplant with Post-Transplant Cyclophosphamide

Ayman Saad, MD, Samantha B Langford, BS, Shin Mineishi, MD, Lawrence S. Lamb, Jr., PhD

Blood (2015) 126 (23): 5462.

https://doi.org/10.1182/blood.V126.23.5462.5462

Published: 2015

Journal Articles

Immune Reconstitution and Chimerism in Allogeneic HSCT Patients Treated with Post-HSCT High Dose Cyclophosphamide As Prophylaxis Against GvHD

Paluri k Ravi, Samina Karim, Gretchen Cloud, Mary Lamb, Samantha Langford, Shin Mineishi, MD, Racquel-innis Shelton, Ayman Saad, MD, Donna Salzman, MD, Lawrence S. Lamb, PhD

Blood (2014) 124 (21): 2474.

https://doi.org/10.1182/blood.V124.21.2474.2474

Published: 2014

Journal Articles

Influence of Pre-Transplant Cytomegalovirus (CMV) Serostatus on Post-Transplant Viral Reactivation after Allogeneic Stem Cell Transplantation in Patients Receiving Post-Transplant Cyclophosphamide for Gvhd Prophylaxis

Ravi K. Paluri, MD, Racquel Shelton, Melissa Gazi, Lawrence S. Lamb, PhD, Ayman Saad, MD, Donna Salzman, MD, Antonio Di Stasi, MD, Shin Mineishi, MD

Blood (2014) 124 (21): 3864.

https://doi.org/10.1182/blood.V124.21.3864.3864

Published: 2014

Journal Articles

Post-Transplant Cyclophosphamide Following Myeloablative Peripheral Blood Stem Cell Transplantation: A Single Institutional Experience

Racquel Innis-Shelton, MD, Donna Salzman, MD, Antonio Di Stasi, MD, Lawrence S. Lamb, PhD, Melissa Gazi, Lisa Williams, RN, Luciano J Costa, MD PhD, Harry Erba, Shin Mineishi, MD, Ayman Saad, MD

Blood (2014) 124 (21): 3911.

https://doi.org/10.1182/blood.V124.21.3911.3911

Published: 2014

Journal Articles

Interim Analysis Of Zoledronic Acid and Interleukin-2 Therapy To Expand Tumoricidal γδ T Cells In Vivo In Patients With Refractory Neuroblastoma

Joseph G Pressey, MD, Adams Julia, BSN, RN, David Kelly, MD, Lawrence S. Lamb, Jr., PhD

Blood (2013) 122 (21): 2029.

https://doi.org/10.1182/blood.V122.21.2029.2029

Published: 2013

Journal Articles

Peripheral Blood γδ T Cell Response to High-Grade Glioma: Implications for Localized Adoptive Immunotherapy

Benjamin Beck, PhD, Richard D Lopez, MD, G Yancey Gillespie, PhD, Hyung Kim, PhD, Gretchen Cloud, Larisa Pereboeva, MD, PhD, Lawrence S. Lamb, Jr., PhD

Blood (2012) 120 (21): 4114.

https://doi.org/10.1182/blood.V120.21.4114.4114

Published: 2012

Journal Articles

PD-1 (CD279) Contributes to the Exhaustion of Gamma/Delta-T Cells in Tumor-Bearing Mice

Richard D Lopez, MD, Shin Mineishi, MD, Lawrence S. Lamb, Jr., PhD, Hyung-Gyoon Kim, PhD, Benjamin Beck, PhD

Blood (2012) 120 (21): 839.

https://doi.org/10.1182/blood.V120.21.839.839

Published: 2012

Journal Articles

DNA Damage Responses and Oxidative Stress in Dyskeratosis Congenita.

Larisa Pereboeva, MD, PhD, Erik Westin, PhD, Toral Patel, Ian Flaniken, Lawrence S. Lamb, Jr., PhD, Aloysius Klingelhutz, PhD, Frederick D Goldman, MD

Blood (2012) 120 (21): 2359.

https://doi.org/10.1182/blood.V120.21.2359.2359

Published: 2012

Journal Articles

ASBMT Risk Group and CD 34+ Dose Predicted for the Development of aGVHD in Allogeneic MRD Transplants When the Donors Who Received a Combined Mobilization and In Vivo TCD Regimen Using rhg-CFS and Dexamethasone.

Khaleel K. Ashraf, MD, Arabella B. Tilden, PhD, Yufeng Li, PhD, Sameer Gupta, MD, Lawrence S. Lamb, PhD, Donna E. Salzman, MD, Richard Lopez, MD, William P. Vaughan, MD

Blood (2007) 110 (11): 5006.

https://doi.org/10.1182/blood.V110.11.5006.5006

Published: 2007

Journal Articles

Effect of Graft Engineering and Post-Transplantation Immunosuppression Regimen on Immunophenotypic Recovery in Recipients of Unrelated Donor Bone Marrow (T-Cell Depletion Trial) in a Multicenter Randomized Phase II-III Trial.

Lawrence S. Lamb, PhD, John E. Wagner, MD, Nancy A. Kernan, MD, Trudy N. Small, MD, Shelly L. Carter, PhD, John S. Thompson, MD, Gretchen A. Cloud, PhD, Sreelatha Meleth, PhD, Anand Kumar, MD, Carolyn A. Keever-Taylor, PhD

Blood (2007) 110 (11): 1067.

https://doi.org/10.1182/blood.V110.11.1067.1067

Published: 2007

NARROW

Inb-100: Pilot Study of Donor Derived, Ex-Vivo Expanded/Activated Gamma Delta T Cell Infusion Following Haploidentical Hematopoietic Stem Cell Transplantation and Post-Transplant Cyclophosphamide

Gamma-Delta (γδ) CAR-T Cells Lacking the CD3z Signaling Domain Enhance Targeted Killing of Tumor Cells and Preserve Healthy Tissues

Inb-100: A Pilot Study of Donor Derived, Ex-Vivo Expanded/Activated Gamma-Delta T Cell (EAGD) Infusion Following Haploidentical Hematopoietic Stem Cell Transplantation and Post-Transplant Cyclophosphamide (PTCy)

Relapse Prophylaxis Post-Haploidentical Bone Marrow Transplantation and Cyclophosphamide (Haplo/Cy) By Infusion of Donor-Derived Expanded/Activated Gd T Cells: A Phase I Trial

First-in-Human Phase I Trial of Adoptive Immunotherapy with Ex Vivo Expanded and Activated Γδ T Cells Following Haploidentical Bone Marrow Transplantation and Post-BMT Cyclophosphamide

A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrelated Donor Hematopoietic Stem Cell Transplantation

Standard Processing of Apheresis Products for HSCT Provides Significant Cost Savings over Automated Processing without Impact on Time or Product Quality

Impact of T-Cell Dose on Gvhd Risk after Allogeneic HLA-Matched PBSC Transplantation

Autologous Hematopoietic Progenitor Cells Mobilization with Combination of Pegfilgrastim and Plerixafor: Efficacy and Cost Assessment

Favorable Immune Reconstitution Profile after Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide

Recovery of CMV-Specific T Cells Following Alternative Donor Allogeneic Transplant with Post-Transplant Cyclophosphamide

Immune Reconstitution and Chimerism in Allogeneic HSCT Patients Treated with Post-HSCT High Dose Cyclophosphamide As Prophylaxis Against GvHD

Influence of Pre-Transplant Cytomegalovirus (CMV) Serostatus on Post-Transplant Viral Reactivation after Allogeneic Stem Cell Transplantation in Patients Receiving Post-Transplant Cyclophosphamide for Gvhd Prophylaxis

Post-Transplant Cyclophosphamide Following Myeloablative Peripheral Blood Stem Cell Transplantation: A Single Institutional Experience

Interim Analysis Of Zoledronic Acid and Interleukin-2 Therapy To Expand Tumoricidal γδ T Cells In Vivo In Patients With Refractory Neuroblastoma

Peripheral Blood γδ T Cell Response to High-Grade Glioma: Implications for Localized Adoptive Immunotherapy

PD-1 (CD279) Contributes to the Exhaustion of Gamma/Delta-T Cells in Tumor-Bearing Mice

DNA Damage Responses and Oxidative Stress in Dyskeratosis Congenita.

ASBMT Risk Group and CD 34+ Dose Predicted for the Development of aGVHD in Allogeneic MRD Transplants When the Donors Who Received a Combined Mobilization and In Vivo TCD Regimen Using rhg-CFS and Dexamethasone.

Effect of Graft Engineering and Post-Transplantation Immunosuppression Regimen on Immunophenotypic Recovery in Recipients of Unrelated Donor Bone Marrow (T-Cell Depletion Trial) in a Multicenter Randomized Phase II-III Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only